Blog

  • Mystery of the mitochondria

    Haley Bridger, June 22nd, 2011 | Filed under

    Postdoctoral scholar Fabiana Perocchi remembers her Ph.D. advisor once telling her that if you want to go from a million candidates to a few thousand, you need to find something that does not agree with the pattern.

    0 Comments
    Read More
  • Molecule makers

    Haley Bridger, June 21st, 2011 | Filed under

    Damian Young’s laboratory at Harvard is a fun place to visit – if you can find it. The lab is housed in the depths of one of the interconnected buildings on Oxford Street, and getting to it requires navigating the twists and turns of many hallways. The lab itself is filled with all kinds of equipment for synthesizing chemical compounds – including an apparatus called a solvent dispensing system, which a chemist can use to decant aliquots of reagents the way a bartender might pour whatever is on tap.

    3 Comments
    Read More
  • DOS library a hit against neglected diseases

    Alice McCarthy, June 20th, 2011

    At the recent Applied Pharmaceutical Chemistry meeting in Boston Ben Munoz, director of Medicinal Chemistry within the Broad’s Chemical Biology Platform, spoke about the exciting work he and others at the Broad have been doing for the past year screening the Broad’s unique small molecule library against targets in infectious and neglected diseases, like malaria and Chagas disease.

    0 Comments
    Read More
  • The Broad goes to the dogs

    Alice McCarthy, June 14th, 2011

    Many people know the Broad Institute as a leader in the study of human genetics. But did you know that as part of this work our researchers look into the genomes of other animals? The following video highlights the work Broad scientists are doing to unravel cancer genes found in the purebred Golden Retriever. The goal of the project is not only to find genes that cause cancer in these dogs but also to make a link with similar cancer-related genes in people. 

     

    0 Comments
    Read More
  • Thanks for the mutations, Dad. You too, Mom.

    Elizabeth Cooney, June 13th, 2011

    Our parents give us about 30 new mutations in our genomes, new research from the 1000 Genomes Project tells us, and whether those mutations come from Mom or Dad varied more than expected.

    0 Comments
    Read More
  • Journey of a cancer sample, part II

    Haley Bridger, June 9th, 2011

    On a drizzly Monday afternoon, clinical pathologist Chin-Lee Wu sits down at an unoccupied desk a few feet away from one of the Broad’s bustling laboratories and gets ready to examine over 100 slides beneath a microscope. Chin-Lee is a surgical pathologist at Massachusetts General Hospital where he specializes in urological cancers, including prostate, kidney, and bladder cancers. For the last three years, he has also served as a consultant pathologist for the Broad, peering at prepared slides of cancer samples and making sense of the cellular disarray.

    0 Comments
    Read More
  • Five questions for Ramnik Xavier

    Elizabeth Cooney, June 8th, 2011 | Filed under

    Ramnik Xavier calls it “learning from human genetics.” That’s how the senior associate member of the Broad Institute describes his research building on the soaring number of genes now known to be implicated in two common disorders, Crohn’s disease and type 1 diabetes.

    0 Comments
    Read More
  • Small molecule detectives

    Haley Bridger, June 6th, 2011

    Robert Flaumenhaft, a research investigator at Beth Israel Deaconess Medical Center, wants to understand a major cause of disease and death. His research lab studies platelets – circulating cells that play a key role in arterial thrombosis, in which a blood clot blocks the flow of blood through an artery potentially leading to a heart attack or other complications. When platelets are activated (turned on), they begin releasing small particles called granules and binding to one another until a clot forms.

    0 Comments
    Read More
  • In the news: Targeting cancer's Achilles heel

    Ellen Clegg, June 3rd, 2011

    Boston Globe reporter Carolyn Johnson writes on today's front page about the push to target cancer with new therapies — among many specialists, the piece quotes Todd Golub, director of the Broad's Cancer Program. Todd and other colleagues discussed the Broad's approach to cancer research in the new Annual Report:

    0 Comments
    Read More
  • Five questions for David Root: RNA Interference explained

    Alice McCarthy, June 2nd, 2011

    At the 5th annual RNAi (RNA interference) and miRNA (microRNA) World Congress held recently in Boston, David Root, Director of the RNAi Platform at the Broad, gave the keynote presentation. I recently caught up with David and asked him to help explain the fundamentals behind RNA interference technology and why it is such a valuable tool for learning about what specific genes do.

    Q1. What is the value of studying RNA interference?

    0 Comments
    Read More